Serum Carbonic Anhydrase 9 Level is Associated With Postoperative Recurrence of Conventional Renal Cell Cancer

Journal of Urology

Volumn 180, Issue 2, 2008, Pages 510-514

  Li, Guorong ^a   Feng, Gang ^a   Gentil Perret, Anne ^a   Genin, Christian ^a   Tostain, Jacques ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

biological markers; CA9 protein, human; carcinoma, renal cell; enzyme linked immunosorbent assay; prognosis

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CARBONIC ANHYDRASE 9 LEVEL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; KIDNEY METASTASIS; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT CANCER; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 46449104314     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.04.024     Document Type: Article

References (18)

1. Lam J.S., Leppert J.T., Figlin R.A., and Belldegrum A.S. Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology 66 (2005) 1
2. Pastorek J., Pastorekova S., Callbaut I., Mornon J.P., Zelnik V., Opavsky R., et al. Cloning and characterisation of MN, a human tumour-associated protein with a domain homologous to carbonic anhydrase and putative helix-loop-helixDNA binding segment. Oncogene 9 (1994) 2877
3. Li G., Feng G., Achour Y., Genin C., and Tostain J. MN/CA9 as a novel molecular marker for the detection of cancer. Exp Opin Med Diag 1 (2007) 91
4. Ivanov S., Liao S.Y., Ivanova A., Danilkovitch-Miagkova A., Tarasova N., Weirich G., et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158 (2001) 905
5. Liao S.Y., Aurelio O.N., Jan K., Zavada J., and Stanbridge E.J. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57 (1997) 2827
6. Bui M.H., Seligson D., Han K.R., Pantuck A.J., Dorey F.G., Huang Y., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802
7. Li G., Cuilleron M., Gentil-Perret A., Cottier M., Passebosc-Faure K., Lambert C., et al. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma. Clin Cancer Res 9 (2003) 6441
8. Li G., Feng G., Gentil-Perret A., Genin C., and Tostain J. CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy. Clin Exp Metastasis 24 (2007) 149
9. Li G., Cuilleron M., Cottier M., Gentil-Perret A., Lambert C., Genin C., et al. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol 49 (2006) 401
10. Zavada J., Zavadova Z., Zat'ovicova M., Hyrsl L., and Kawaciuk I. Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients. Br J Cancer 89 (2003) 1067
11. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. UICC International Union Against Cancer. 6th edition (2003), Wiley-Liss, New York 193
12. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655
13. Margel D., Tal R., and Baniel J. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. J Urol 178 (2007) 2297
14. Dorai T., Sawczuk I.S., Pastorek J., Wiernik P.H., and Dutcher J.P. The role of carbonic anhydrase IX overexpression in kidney cancer. Eur J Cancer 41 (2005) 2935
15. Skolarikos A., Alivizatos G., Laguna P., and de la Rosette J. A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 51 (2007) 1490
16. Atkins M., Regan M., McDermott D., Mier J., Stanbridge E., Youmans A., et al. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11 (2005) 3714
17. Bui M.H., Visapaa H., Seligson D., Kim H., Ham K.R., Huang Y., et al. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. J Urol 171 (2004) 2461
18. Leibovich B.C., Sheinin Y., Lohse C.M., Thompson R.H., Cheville J.C., Zavada J., et al. Cabonic anhydrase IX is not an indepedent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol 25 (2007) 4757